http://pubs.acs.org/doi/abs/10.1021/jacs.6b11013?journalCode=jacsat
J. Am. Chem. Soc., Just Accepted Manuscript
DOI: 10.1021/jacs.6b11013
Publication Date (Web): December 20, 2016
Copyright © 2016 American Chemical Society
Abstract
Nanotechnology-mediated
antioxidative therapy is emerging as a novel strategy for treating a
myriad of important diseases through scavenging excessive reactive
oxygen and nitrogen species (RONS), a mechanism critical in disease
development and progression. However, similar to antioxidative enzymes,
currently studied nano-antioxidants have demonstrated scavenging
activity to specific RONS, and sufficient antioxidative effects against
multiple RONS generated in diseases remain elusive. Here we propose to
develop bioinspired melanin nanoparticles (MeNPs) for more potent and
safer antioxidative therapy. While melanin is known to function as a
potential radical scavenger, its antioxidative mechanisms are far from
clear and its applications for the treatment of RONS-associated diseases
have yet to be well explored. In this study, we provide for the first
time exhaustive characterization of the activities of MeNPs against
multiple RONS including O2●−, H2O2, ●NO, ●OH, and ONOO–,
the main toxic RONS generated in diseases. The potential of MeNPs for
antioxidative therapy has also been evaluated in vitro and in a rat
model of ischemic stroke. In addition to the broad defense against these
RONS, MeNPs can also attenuate the RONS-triggered inflammatory
responses through suppressing the expression of inflammatory mediators
and cytokines. In vivo results further demonstrate that these unique
multi-antioxidative, anti-inflammatory and biocompatible features of
MeNPs contribute to their effective protection of ischemic brains with
negligible side effects.
No comments:
Post a Comment